Home > Trustees and Founders Circle > Henry I. Miller, M.S., M.D. >

Henry I. Miller, M.S., M.D.

Printer Format E-mail Information

Dr. Henry I. Miller is a research fellow at the Hoover Institution, where his research focuses on public policy toward science and technology. It encompasses a number of areas, including pharmaceutical development, the new biotechnology, models for regulatory reform, and the emergence of new viral diseases.

Miller joined the Food and Drug Administration in 1979 and served in a number of posts. He was the medical reviewer for the first genetically engineered drugs evaluated by the FDA and was instrumental in the rapid licensing of human insulin and human growth hormone. Thereafter, he was a special assistant to the FDA commissioner, with responsibility for biotechnology issues, and from 1989 to 1993 was the founding director of the FDA's Office of Biotechnology. During his government service, Miller participated frequently in various expert and policy panels as a representative of the FDA or the U.S. government. While a government official, Miller was the recipient of numerous awards and citations.

After leaving government service, Miller became the Robert Wesson Fellow in Scientific Philosophy and Public Policy at the Hoover Institution, 1994–96.

Since then, Miller has become well known not only for contributions to scholarly journals but also for articles and books that make science, medicine, and technology more accessible to non-experts. His work has been published widely and in many languages. Monographs include Policy Controversy in Biotechnology: An Insider's View, Biotechnology Regulation: The Unacceptable Costs of Excessive Regulation, To America's Health: A Model for Reform of the Food and Drug Administration, and The Frankenfood Myth: How Protest and Politics Threaten the Biotech Revolution. Barron's selected The Frankenfood Myth one of the Twenty-Five Best Books of 2004. Miller has published extensively in publications worldwide, including The Lancet, Journal of the American Medical Association, Science, the Nature family of journals, Chronicle of Higher Education, Forbes, National Review, Wall Street Journal, New York Times, and Financial Times. He is a regulator  commentator on the nationally syndicated John Batchelor Program on ABC radio and appears frequently on TV.

Miller is an adjunct scholar at several thinktanks and serves on numerous editorial boards.

(Profile posted Nov. 2006.)